Free Trial

13 Stocks With Strong Institutional Buying - 9 of 13

 
 

Cencora (NYSE:COR)

Net Inflows of from Institutional Investors in Dollars
$9,888,539,415.00
Net Inflows of from Institutional Investors in Shares
43,964,697
Number of Institutional Transactions in the Last 90 Days
824

Inflows and Outflows by Quarter for Cencora (NYSE:COR)

Cencora logoCencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. Read More 
 
 

WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.

Take these 4 steps today to protect your retirement NOW